T-cell Precursor Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for T-cell Precursor Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations [Phase 2]
Phase 2 trial evaluating the combination of venetoclax and azacitidine for newly diagnosed early T-cell precursor acute lymphoblastic leukem…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL [Phase 3]
This entry notes a Phase 3 clinical trial comparing the VHAG regimen to traditional chemotherapy in newly diagnosed early T-cell precursor a…
-
CLINICAL_TRIALS withdrawal · 2018-07-26Clinical Trial Update: Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL) [Phase 2]
A Phase 2 trial evaluating daratumumab for relapsed/refractory B-cell or T-cell precursor acute lymphoblastic leukemia has been withdrawn.